Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo significant changes detected on the Study Details page; the study overview, objectives, eligibility criteria, and plan appear unchanged. Any minor formatting differences are not considered impactful.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check42 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference2%

- Check49 days agoChange Detected- Terminology updated: 'Clear cell renal carcinoma' replaced with 'Clear cell carcinoma of kidney'. - Version bumped from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, a minor UI change.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.SummaryDifference0.2%

- Check78 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies, while removing several related medical topics and terms.SummaryDifference2%

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.